VCHP EDGE THERAPEUTICS SCHEDULE 13D 10-16-15

Company

PDS Biotechnology Corp

Filed

October 16, 2015

Accession Number

0001596770-15-000052

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →